Neuralink, the
groundbreaking brain-chip startup founded by Elon Musk, has successfully completed its inaugural human implant
procedure. Elon Musk himself
confirmed this major achievement, sharing his excitement on the X social media platform the following
day. The early results are promising, with the detection of neuron spikes,
indicating the activity of specialized cells transmitting information
throughout the brain and body via electrical and chemical signals, as defined
by the National Institute of Health.
Going for a walk with Optimus pic.twitter.com/6mLJCUp30F
— Elon Musk (@elonmusk) January 31, 2024
Last year, Neuralink
received approval from the U.S. Food and Drug Administration to embark on its
first human trial, a significant step in the company's mission to address
paralysis and various neurological conditions. In September, Neuralink announced approval to recruit participants for the
trial, which involves a robot precisely implanting a BRAIN-COMPUTER INTERFACE (BCI) in the region controlling movement
intentions. The ultimate goal is to empower individuals to control a computer
cursor or keyboard solely through their thoughts.
Neuralink's
implant threads are described as "ultra-fine,"
facilitating signal transmission within participants' brains. Elon Musk
revealed on X that the initial offering from Neuralink would be named Telepathy. The PRIME Study, conducted by
the startup, focuses on assessing the safety of the wireless brain-computer
interface and the surgical robot. This groundbreaking development marks a
significant stride towards Neuralink's vision of enhancing human capabilities
through advanced BRAIN-CHIP TECHNOLOGY.
Post a Comment